Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Contemporary evidence supports device-based transcatheter interventions for the
management of patients with structural heart disease. These procedures, which include …

Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

Background Tricuspid regurgitation (TR) is a frequent disease with a progressive increase in
mortality as disease severity increases. Transcatheter therapies for treatment of TR may offer …

Objectives The aim of this study was to report the midterm outcomes at 1 year in the
expanded first-in-human experience with the transfemoral EVOQUE system (Edwards …

Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in
procedural complications. Despite this, clinically relevant bleeding still occurs in a non …

A large amount of evidence supports the widespread use of transcatheter aortic valve
replacement (TAVR) among patients who are at low to intermediate risk for surgery …

Introduction Aortic valve stenosis (AS) is present in up to 10% of individuals over age 80
years. Transcatheter aortic valve replacement (TAVR) has become the most common …

The performance of transcatheter aortic valve replacement has expanded considerably
during the past decade. Technological advances and refinement in implantation techniques …

Objectives No standardized algorithm exists to identify patients at risk of bleeding after
transcatheter aortic valve replacement (TAVR). The aim of this study was to generate and …